Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on our website or click to take an action on their website ...

Johnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) rendered a positive opinion for the expanded use of the ...

(RTTNews) - AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and ... are currently under review in Japan and several other countries ...

Different methods employ different definitions. Chart-review studies define medication errors as errors in the ordering, transcribing, dispensing, administering, or monitoring of a medication.

The European Commission, which grants central marketing authorizations in the European Union (EU), will review the ... Based on the positive CHMP opinion, Bavarian Nordic will now also submit a ...

has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indications are for add-on maintenance treatment of asthma in ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted ...

This feature story is part of the City of Ottawa Service Reviews: an initiative aimed at ensuring our services are meeting your needs. Visit ottawa.ca/YourIdeas today. Ottawa is filled with incredible ...

ImmunityBio (IBRX) announced the European Medicines Agency has accepted for review and begun assessing the marketing authorization application for Anktiva in combination with Bacillus Calmette ...